CU6CLARITY PHARMACEUTICALS LTDMarket sensitive

Clarity receives $9.8 million R&D tax incentive refund

Date and time
Announcement type
Periodic Reports
Show details
Category
Reports
Report codes
03014, 12008
Sector
Health Care
Industry group
Pharmaceuticals, Biotechnology & Life Sciences